39.50
price down icon1.62%   -0.65
pre-market  Pre-market:  39.46   -0.04   -0.10%
loading
Qiagen Nv stock is traded at $39.50, with a volume of 1.59M. It is down -1.62% in the last 24 hours and up +2.86% over the past month. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
See More
Previous Close:
$40.15
Open:
$40.18
24h Volume:
1.59M
Relative Volume:
1.47
Market Cap:
$8.54B
Revenue:
$1.97B
Net Income/Loss:
$92.93M
P/E Ratio:
97.15
EPS:
0.4066
Net Cash Flow:
$459.60M
1W Performance:
-0.43%
1M Performance:
+2.86%
6M Performance:
-14.49%
1Y Performance:
-9.62%
1-Day Range:
Value
$39.38
$40.20
1-Week Range:
Value
$39.31
$40.27
52-Week Range:
Value
$37.74
$49.30

Qiagen Nv Stock (QGEN) Company Profile

Name
Name
Qiagen Nv
Name
Phone
-
Name
Address
-
Name
Employee
5,800
Name
Twitter
@QIAGEN
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
QGEN's Discussions on Twitter

Compare QGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
QGEN
Qiagen Nv
39.50 8.54B 1.97B 92.93M 459.60M 0.4066
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
482.97 182.21B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
200.39 143.37B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
418.57 33.92B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
114.05 32.53B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
171.24 30.19B 15.41B 1.37B 2.11B 7.50

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-19-25 Downgrade Robert W. Baird Outperform → Neutral
Jan-06-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-10-24 Upgrade Jefferies Hold → Buy
Oct-17-24 Downgrade HSBC Securities Buy → Hold
Jun-27-24 Upgrade Wolfe Research Peer Perform → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Dec-07-23 Upgrade Goldman Neutral → Buy
Sep-12-23 Initiated Robert W. Baird Outperform
May-23-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-18-22 Initiated Morgan Stanley Equal-Weight
Jan-18-22 Upgrade DZ Bank Hold → Buy
Oct-15-21 Resumed Cowen Market Perform
Oct-14-21 Initiated Redburn Buy
Jul-14-21 Downgrade Kepler Buy → Hold
Jun-03-21 Initiated Goldman Neutral
Oct-06-20 Resumed BofA Securities Buy
Sep-28-20 Upgrade Kepler Hold → Buy
Aug-24-20 Upgrade Citigroup Neutral → Buy
Aug-20-20 Resumed JP Morgan Overweight
Aug-17-20 Upgrade Berenberg Hold → Buy
Aug-14-20 Upgrade Deutsche Bank Hold → Buy
Aug-14-20 Upgrade Exane BNP Paribas Neutral → Outperform
Mar-04-20 Downgrade Berenberg Buy → Hold
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Dec-26-19 Resumed BofA/Merrill Underperform
Nov-15-19 Initiated Stifel Hold
Nov-14-19 Upgrade Evercore ISI In-line → Outperform
Nov-14-19 Upgrade JP Morgan Underweight → Overweight
Nov-14-19 Upgrade Kepler Reduce → Hold
Oct-17-19 Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19 Downgrade Kepler Hold → Reduce
Oct-08-19 Downgrade Barclays Overweight → Equal Weight
Oct-08-19 Downgrade Deutsche Bank Buy → Hold
Oct-08-19 Downgrade JP Morgan Neutral → Underweight
View All

Qiagen Nv Stock (QGEN) Latest News

pulisher
04:52 AM

Personalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases - GlobeNewswire Inc.

04:52 AM
pulisher
Apr 01, 2025

Qiagen introduces QIAprep Plasmodium kit to strengthen malaria research efforts - BioSpectrum Asia

Apr 01, 2025
pulisher
Apr 01, 2025

Revolutionary Malaria Test Kit: QIAGEN's New Solution Detects 5 Species with Single-Parasite Sensitivity - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

QIAGEN N.V. Files 2024 Annual Report with SEC - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results - DutchNews.nl

Mar 31, 2025
pulisher
Mar 31, 2025

PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

QIAGEN Releases Full 2024 Annual Report: Access Complete Financial Data and Analysis - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

QIAGEN NV : Jefferies reiterates its Buy rating - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 81% - simplywall.st

Mar 28, 2025
pulisher
Mar 18, 2025

Qiagen Manager Pledges Shares in Securities Lending Transaction - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView

Mar 18, 2025
pulisher
Mar 16, 2025

QGEN Stock Might Rise Following Partnership With Genomics England - MSN

Mar 16, 2025
pulisher
Mar 12, 2025

Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

Digital Genome Market to Witness Remarkable Growth with QIAGEN, GenomeMe Inc., NanoString Technologies - openPR

Mar 11, 2025
pulisher
Mar 08, 2025

The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses - Yahoo Finance

Mar 08, 2025
pulisher
Mar 07, 2025

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B - Medical Device Network

Mar 07, 2025
pulisher
Mar 06, 2025

Qiagen at TD Cowen Conference: Strategic Growth Plans Unveiled - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday -March 06, 2025 at 09:14 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel -March 06, 2025 at 04:04 am EST - MarketScreener

Mar 06, 2025
pulisher
Mar 06, 2025

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio - Silicon Canals

Mar 06, 2025
pulisher
Mar 05, 2025

Market is not liking Qiagen's (NYSE:QGEN) earnings decline as stock retreats 4.7% this week - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

Analyzing Tevogen Bio (NASDAQ:TVGN) and Qiagen (NYSE:QGEN) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

QIAGEN Announces Managerial Transactions Involving Performance Stock Units - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

QIAGEN Announces Managerial Stock Transaction - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Qiagen Announces Managerial Stock Unit Grant - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Qiagen Announces Managerial Stock Transactions - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Qiagen Announces Managerial Transaction Involving Restricted Stock Units - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

Relative Strength Alert For Qiagen - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

BioMérieux: complaint lodged by German company Qiagen -March 03, 2025 at 05:57 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing - sharewise

Mar 03, 2025
pulisher
Mar 03, 2025

Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux -March 03, 2025 at 05:02 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

How QIAGEN's Patent Lawsuit Against bioMérieux Could Reshape the TB Testing Market - Stock Titan

Mar 03, 2025
pulisher
Mar 03, 2025

What is Zacks Research’s Estimate for Qiagen Q1 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property -March 03, 2025 at 01:04 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 02, 2025

Zacks Research Issues Negative Estimate for Qiagen Earnings - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Zacks Research Forecasts Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Qiagen (NYSE:QGEN) Reaches New 12-Month LowWhat's Next? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Qiagen (NYSE:QGEN) Receives Average Rating of “Hold” from Brokerages - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Qiagen stock touches 52-week low at $38.48 amid market shifts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Qiagen stock touches 52-week low at $38.48 amid market shifts By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 25, 2025

Qiagen N.V.: Some Clarity Needed Before Buying The Dip (NYSE:QGEN) - Seeking Alpha

Feb 25, 2025
pulisher
Feb 24, 2025

Genetic Testing Market Future Business Opportunities - openPR

Feb 24, 2025
pulisher
Feb 24, 2025

AlphaValue/Baader Europe Upgrades Qiagen to Buy, Trims PT -February 24, 2025 at 07:17 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Qiagen (NYSE:QGEN) Stock Rating Lowered by Baird R W - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

Qiagen (NYSE:QGEN) Reaches New 1-Year LowHere's What Happened - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

Qiagen (NYSE:QGEN) Rating Lowered to Neutral at Robert W. Baird - MarketBeat

Feb 23, 2025

Qiagen Nv Stock (QGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$169.28
price up icon 0.05%
$140.65
price down icon 0.54%
diagnostics_research LH
$232.65
price down icon 0.04%
diagnostics_research WAT
$356.00
price down icon 3.41%
diagnostics_research MTD
$1,156.38
price down icon 2.08%
diagnostics_research IQV
$171.24
price down icon 2.87%
Cap:     |  Volume (24h):